Global Smart Insulin Pens Market By Type (First Generation Pens and Second Generation Pens), By Usability (Prefilled and Reusable), By End-User (Hospitals & Clinics, Ambulatory Surgical Centers, and Home Care Settings), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends, and Forecast 2023-2032
- Published date: Oct 2023
- Report ID: 12028
- Number of Pages: 267
- Format:
-
keyboard_arrow_up
-
-
- Medtronic plc
- Eli Lilly and Company
- Novo Nordisk A/S Company Profile
- Sanofi S.A
- Digital Medics Pty Ltd.
- Bigfoot Biomedical, Inc.
- Berlin-Chemie AG
- Jiangsu Deflu Medical Device Co. Ltd.
- Emperra GmbH E-Health Technologies
- Other Key Players
- settingsSettings
Our Clients
- 12028
- Oct 2023
Trusted by more than 17382 organizations globally
✖
Request a Sample Report
We'll get back to you as quickly as possible
|
Single User
$6,000
$3,999
USD / per unit
save 24%
|
Multi User
$8,000
$5,999
USD / per unit
save 28%
|
Corporate User
$10,000
$6,999
USD / per unit
save 32%
|
|
|---|---|---|---|
| e-Access | |||
| Report Library Access | |||
| Data Set (Excel) | |||
| Company Profile Library Access | |||
| Interactive Dashboard | |||
| Free Custumization | No | up to 10 hrs work | up to 30 hrs work |
| Accessibility | 1 User | 2-5 User | Unlimited |
| Analyst Support | up to 20 hrs | up to 40 hrs | up to 50 hrs |
| Benefit | Up to 20% off on next purchase | Up to 25% off on next purchase | Up to 30% off on next purchase |
| Buy Now ($ 3,999) | Buy Now ($ 5,999) | Buy Now ($ 6,999) |
